Literature DB >> 33090413

Venous thromboembolism during mycoplasma pneumoniae infection: case report and review of the literature.

A Mirijello1, A La Marca, M M D'Errico, S Curci, G Vendemiale, E Grandone, S De Cosmo.   

Abstract

Mycoplasma pneumoniae infection is frequent but generally mild or self-limiting. Approximately 10% of cases develop clinical signs of pneumonia with "atypical" radiographic pattern. However, mycoplasma pneumoniae can be responsible for a variety of extrapulmonary manifestations, potentially involving all systems and apparatuses. Although exact pathophysiological mechanisms are not completely known, these could be secondary to direct invasion of the target organ, immunological damage due to molecular mimicry or vascular obstruction. A 45-year-old man was admitted to Internal Medicine Unit because of fever, dry cough and fatigue lasting 15 days. Fever disappeared after starting clarithromycin. About 72 h after admission the patient complained of right calf pain and tachypnea. The presence of anti-mycoplasma antibodies suggested mycoplasma pneumoniae infection. Moreover, a diagnosis of venous thrombo-embolism was performed. Given the absence of classical risk factors for thrombosis, patient was investigated for inherited and acquired thrombophilia and tested positive for antiphospholipid antibodies. A review of the English literature on the association between m. pneumoniae and pulmonary embolism will be provided in order to underline the possible pathogenetic role of antiphospholipid antibodies in this setting. Clinicians should outweigh risk and benefits for LMWH prophylaxis case by case considering these adjunctive pro-thrombotic mechanisms in patients m. pneumoniae infection.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33090413     DOI: 10.26355/eurrev_202010_23223

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  4 in total

1.  The role of targeted regulation of COX11 by miR-10a-3p in the development and progression of paediatric mycoplasma pneumoniae pneumonia.

Authors:  Wenhong Li; Xin Ding; Rui Zhao; Donghui Xiong; Zhiping Xie; Jing Xu; Meiling Tan; Chunyu Li; Chunfu Yang
Journal:  J Thorac Dis       Date:  2021-09       Impact factor: 2.895

2.  A Rare Case of Severe Hemolytic Anemia and Pulmonary Embolism Secondary to Mycoplasma pneumoniae Infection.

Authors:  Aravind Sunderavel Kumaravel Kanagavelu; Sateesh K Nagumantry; Satyanarayana V Sagi; Samson O Oyibo
Journal:  J Med Cases       Date:  2022-03-05

Review 3.  Thrombosis associated with mycoplasma pneumoniae infection (Review).

Authors:  Jingwei Liu; Yumei Li
Journal:  Exp Ther Med       Date:  2021-07-07       Impact factor: 2.447

4.  The Level of D-Dimer Is Positively Correlated With the Severity of Mycoplasma pneumoniae Pneumonia in Children.

Authors:  Yan Zheng; Lingling Hua; Qiannan Zhao; Mengyao Li; Meixia Huang; Yunlian Zhou; Yingshuo Wang; Zhimin Chen; Yuanyuan Zhang
Journal:  Front Cell Infect Microbiol       Date:  2021-07-15       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.